Envestnet Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-13,029
Closed -$116K 3222
2020
Q2
$116K Buy
+13,029
New +$112K ﹤0.01% 2973
2017
Q3
Sell
-1,607
Closed -$12K 3087
2017
Q2
$12K Hold
1,607
﹤0.01% 2687
2017
Q1
$14K Sell
1,607
-1,140
-41% -$11.9K ﹤0.01% 2734
2016
Q4
$29K Sell
2,747
-830
-23% -$11.1K ﹤0.01% 2584
2016
Q3
$58K Sell
3,577
-93
-3% -$1.31K ﹤0.01% 2545
2016
Q2
$35K Buy
3,670
+38
+1% +$414 ﹤0.01% 2849
2016
Q1
$51K Buy
+3,632
New +$37.6K ﹤0.01% 2716

Other funds holding NPTN

Envestnet Asset Management's NPTN Position: Q3 2020 in Review

Envestnet Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2020, closing a stake of 13,029 shares — an estimated $116K sold.

Envestnet Asset Management first reported a position in NPTN in Q1 2016 and held it in 7 quarters. The position peaked at $116K in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

  • Envestnet Asset Management reported no remaining NEOPHOTONICS CORP position as of Q3 2020 after selling out during the quarter.
  • Envestnet Asset Management sold 13,029 NEOPHOTONICS CORP shares in Q3 2020, an estimated $116K.
  • Envestnet Asset Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 7 quarters.
  • Envestnet Asset Management's NEOPHOTONICS CORP position peaked at $116K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Envestnet Asset Management's 13F filing for Q3 2020, filed 9 Oct 2020.